Pfizer stops selling popular Corex cough syrup in India after ban

Corex brought in sales of about 1.76 billion rupees in the nine months.

 

Mumbai: US pharmaceutical giant Pfizer Inc’s India unit said on Monday it had stopped selling its popular Corex cough syrup, after regulators banned it saying it was likely to pose a risk to humans.

Corex is a...

 

headlinesview.com/pfizer-stops-selling-popular-corex-coug...

Done